NDC codes

FDA NDC Directory
Product NDC (as listed)59353-002Labeler and product segments. Claims need a package NDC.
Product NDC at billing width59353-0002Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
59353-002-10593530002105935300021010 VIAL, SINGLE-DOSE in 1 CARTON (59353-002-10) / 1 mL in 1 VIAL, SINGLE-DOSE (59353-002-01)Marketed from Jun 18, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Retacrit
Generic name (nonproprietary)
epoetin alfa-epbx
Active ingredients
Epoetin — 2000 [iU]/mL
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Labeler
Vifor (International) Inc.NDC labeler code 59353
Product type
Prescription drug
Marketing category
BLA — Biologics License ApplicationApplication BLA 125545
Marketing start
Listing expires
Other FDA classes
Erythropoietin (Chemical structure)Increased Erythroid Cell Production (Physiologic effect)
Identifiers
Product ID 59353-002_5626304b-344f-4155-9afa-d7cfe733d819SPL ID 5626304b-344f-4155-9afa-d7cfe733d819SPL set ID e6e4dd0c-25ca-40b2-ba6b-6138a68621feRxCUI 2047591, 2047596, 2047600, 2047602, 2047606, 2047608, 2047612, 2047614, 2463731, 2463733, 2463735, 2463737UNII 64FS3BFH5W

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N459353000210 followed by a unit qualifier and the quantity

Package 59353-0002-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

RETACRIT is an erythropoiesis-stimulating agent (ESA) indicated for: • Treatment of anemia due to o Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis ( 1.1 ). o Zidovudine in patients with Human Immunodeficiency Virus (HIV) infection ( 1.2 ). o The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy ( 1.3 ). • Reduction of allogeneic red blood cell (RBC) transfusions in patients undergoing elective, noncardiac, nonvascular surgery ( 1.4 ). Limitations of Use RETACRIT has not been shown to improve quality of life, fatigue, or patient well-being ( 1.5 ). RETACRIT is not indicated f…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59353-002

What is NDC 59353-002?
59353-002 is the product NDC for Retacrit (epoetin alfa-epbx), Epoetin 2000 [iU]/mL injection, solution, listed with the FDA by Vifor (International) Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Retacrit (Epoetin alfa-epbx).
What is the active ingredient?
Epoetin.
Who is the labeler?
Vifor (International) Inc., NDC labeler code 59353. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Retacrit?
12 other product NDCs are listed under this name. See all Retacrit NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Retacrit NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Retacritepoetin alfa-epbxEpoetin 20000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-131100069-1311-10
Retacritepoetin alfa-epbxEpoetin 10000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-131800069-1318-10
Retacritepoetin alfa-epbxEpoetin 20000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousVifor (International) Inc.59353-12059353-0120-10
Retacritepoetin alfa-epbxEpoetin 10000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousVifor (International) Inc.59353-22059353-0220-10
Retacritepoetin alfa-epbxEpoetin 2000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-130500069-1305-10
Retacritepoetin alfa-epbxEpoetin 3000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-130600069-1306-10
Retacritepoetin alfa-epbxEpoetin 4000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-130700069-1307-10
Retacritepoetin alfa-epbxEpoetin 10000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-130800069-1308-10
Retacritepoetin alfa-epbxEpoetin 40000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-130900069-1309-04
Retacritepoetin alfa-epbxEpoetin 3000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousVifor (International) Inc.59353-00359353-0003-10

All 13 Retacrit NDCs

Other NDCs under BLA 125545

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125545
ProductStrengthForm · routeLabelerProduct NDC
Retacritepoetin alfa-epbxEpoetin 3000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-1306
Retacritepoetin alfa-epbxEpoetin 40000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-1309
Retacritepoetin alfa-epbxEpoetin 4000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-1307
Retacritepoetin alfa-epbxEpoetin 10000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousVifor (International) Inc.59353-010
Retacritepoetin alfa-epbxEpoetin 3000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousVifor (International) Inc.59353-003
Retacritepoetin alfa-epbxEpoetin 4000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousVifor (International) Inc.59353-004
Retacritepoetin alfa-epbxEpoetin 10000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousVifor (International) Inc.59353-220
Retacritepoetin alfa-epbxEpoetin 20000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousVifor (International) Inc.59353-120
Retacritepoetin alfa-epbxEpoetin 2000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-1305
Retacritepoetin alfa-epbxEpoetin 10000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-1318
Retacritepoetin alfa-epbxEpoetin 20000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-1311
Retacritepoetin alfa-epbxEpoetin 10000 [iU]/mLInjection, SolutionIntravenous, SubcutaneousPfizer Laboratories Div Pfizer Inc0069-1308

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in